Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Abilify Maintena

Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 32

HOS-129464 · Präparat HOS-096717

Metabolism and Weight increaseda Hyperglycaemia Anorexia nutrition disorders Diabetes mellitus Hypercholesterolaemia Decreased appetiteb Weight decreased Hyperinsulinaemia Hyponatraemia Hyperlipidaemia Hypertriglyceridaemia Appetite disorder Psychiatric Agitation Suicidal ideation Completed suicide disorders Anxiety Psychotic disorder Suicide attempt Restlessness Hallucination Gambling disorder Insomnia Delusion Impulse-control Hypersexuality disorder Panic reaction Binge eating Depression Compulsive shopping Affect lability Poriomania Apathy Nervousness Dysphoria Aggression Sleep disorder Bruxism Libido decreased Mood altered Nervous system Extrapyramidal Dystonia Neuroleptic malignant disorders disorder Tardive dyskinesia syndrome Akathisia Parkinsonism Generalised tonic- Tremor Movement disorder clonic seizure Dyskinesia Psychomotor Serotonin syndrome Sedation hyperactivity Speech disorder Somnolence Restless legs syndrome Dizziness Cogwheel rigidity Headache Hypertonia Bradykinesia Drooling Dysgeusia Parosmia Eye disorders Oculogyric crisis Vision blurred Eye pain Diplopia Photophobia Cardiac disorders Ventricular Sudden death extrasystoles Cardiac arrest Bradycardia Torsades de pointes Tachycardia Ventricular arrhythmia Electrocardiogram T QT prolonged wave amplitude decreased Electrocardiogram abnormal Electrocardiogram T wave inversion Vascular disorders Hypertension Syncope Orthostatic Venous embolism hypotension (including pulmonary Blood pressure embolism and deep increased vein thrombosis)

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.